Cargando…
Platelet Activation in Cats with Hypertrophic Cardiomyopathy
BACKGROUND: Cats with hypertrophic cardiomyopathy (HCM) are at risk for development of systemic thromboembolic disease. However, the relationship between platelet activation state and cardiovascular parameters associated with HCM is not well described. OBJECTIVES: To characterize platelet activation...
Autores principales: | Tablin, F., Schumacher, T., Pombo, M., Marion, C.T., Huang, K., Norris, J.W., Jandrey, K.E., Kittleson, M.D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857988/ https://www.ncbi.nlm.nih.gov/pubmed/24612013 http://dx.doi.org/10.1111/jvim.12325 |
Ejemplares similares
-
Cardiac Troponin I and T as Prognostic Markers in Cats with Hypertrophic Cardiomyopathy
por: Langhorn, R., et al.
Publicado: (2014) -
Plasma Cardiac Troponin I Concentration and Cardiac Death in Cats with Hypertrophic Cardiomyopathy
por: Borgeat, K., et al.
Publicado: (2014) -
A Randomized Study Assessing the Effect of Diet in Cats with Hypertrophic Cardiomyopathy
por: Freeman, L.M., et al.
Publicado: (2014) -
Acute Effects of Ivabradine on Dynamic Obstruction of the Left Ventricular Outflow Tract in Cats with Preclinical Hypertrophic Cardiomyopathy
por: Blass, K.A., et al.
Publicado: (2014) -
Concurrent Diseases and Conditions in Cats with Renal Infarcts
por: Hickey, M.C., et al.
Publicado: (2014)